Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

This publication has 20 references indexed in Scilit:

• The New Human Kallikrein Gene Family: Implications in Carcinogenesis
  Trends in Endocrinology & Metabolism, 2000
• Prostate-specific Antigen: Its Usefulness in Clinical Medicine
  Trends in Endocrinology & Metabolism, 1998
• Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease
  JAMA, 1998
• Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate
  Critical Reviews in Clinical Laboratory Sciences, 1998
• Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2
  Biochemical and Biophysical Research Communications, 1997
• Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern‐blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies
  International Journal of Cancer, 1993
• Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia
  International Journal of Cancer, 1991
• In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate
  Journal of Urology, 1990
• Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens
  Urological Research, 1990
• Expression of the gene coding for human prostate‐specific antigen and related hGK‐1 in benign and malignant tumors of the human prostate
  International Journal of Cancer, 1990